HDAC6 and kidney disorder: Growing evidence has demonstrated that the expression and activity of HDAC6 are increased in various kidney diseases (Shi et al. 2017; Choi et al. 2015; Cebotaru et al. 2016), and inhibiting HDAC6 has mitigated the progression of kidney injury.